Paediatric extensions to supplementary protection certificates
By Ed Vickers
In addition to monopoly protection in the form of a patent and a supplementary protection certificate (SPC), medicinal products may also be protected by a paediatric extension, which extends the lifetime of an SPC by a further six months.
The governing legislation is the Paediatric Regulation (Regulation (EC) 1901/2006). The aim of the legislation, among other things, is to: ‘facilitate the development and accessibility of medicinal products for use in the paediatric population; to ensure that medicinal products used to treat the paediatric population are subject to ethical research of high quality and are appropriately authorised for use in the paediatric population; and to improve the information available on the use of medicinal products in the various paediatric populations’ …
If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
The OFT finds a significant imbalance of power between ICT suppliers and public sector buyers that prevents effective competition.
The MHRA offers useful guidance on the difference between apps that are regulated as medical devices and those that are related to healthcare but do not qualify.
Analysis from The Lawyer
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world
Financial disputes are starting to dominate the English courts as the long-awaited fallout from the downturn finally comes to town